Claudins in human cancer: A review

Histology and Histopathology

Volumn 25, Issue 1, 2010, Pages 83-90

  Ouban, Abderrahman ^a   Ahmed, Atif A ^b  

^a SABA UNIVERSITY SCHOOL OF MEDICINE   (Netherlands)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Cancer; Claudins; Immunohistochemistry

Indexed keywords

CLAUDIN;

HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW; TIGHT JUNCTION;

CLAUDINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; TIGHT JUNCTIONS;

EID: 74749100893     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Agarwal R., D'Souza T. and Morin P.J. (2005). Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res. 65, 7378-7385.
2. Al Moustafa A., Alaoui-Jamali M.A., Batist G., Henandez-Perez M., Serruya C., Alpert L., Black M.J., Sladeck R. and Foulkes W. (2002). Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 21, 2634-2640.
3. Aung P.P., Mitani Y., Sanada Y., Nakayama H., Matsusaki K. and Yasui W. (2006). Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Virchows Arch. 448, 428-434
4. Balda M.S., Gonzalez-Mariscal L., Contreras R.G., Macias-Silva M., Torres-Marquez M.E., Garcia-Sainz J.A. and Cereijido M. (1991). Assembly and sealing of tight junctions: possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin. J. Membr. Biol. 122, 193-202.
5. Bello I.Q., Vilen S.T., Niinimaa A., Kantola S., Soini Y. and Salo T. (2008). Expression of claudins 1, 4, 5 and 7 and occludin and relationship with prognosis in squamous cell carcinoma of the tongue. Hum. Pathol. 39, 1212-1220
6. Billings S.D., Walsh S.V., Fisher C., Nusrat A., Weiss S.W. and Folpe A.L. (2004). Aberrant expression of tight junction-related proteins ZO-1, claudin-1 and occludin in synovial sarcoma: an immunohistochemical study with ultrastructural correlation. Mod. Pathol. 17, 141-149.
7. Borlak J., Meier T., Halter R., Spanel R. and Spanel-Borowski K. (2005). Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours. Oncogene 24, 1809-1819.
8. Borok Z., Hami A., Danto S.I., Lubman R.L., Kim K.J. and Crandall E.D. (1996). Effects of EGF on alveolar epithelial junctional permeability and active sodium transport. Am. J. Physiol. Lung Cell. Mol. Physiol. 270, L559-L565.
9. Chen M.C., Goliger J., Bunnett N. and Soll A.H. (2001). Apical and basolateral EGF receptors regulate gastric mucosal paracellular permeability. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G264-G272.
10. Cheung S.T., Leung K.L., Ip Y.C., Chen X., Fong D.Y., Ng I.O., Fan S.T. and So S. (2005). Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin. Cancer Res. 11, 551-556.
11. Cohn M.L., Goncharuk V.N., Diwan A.H., Zhang P.S., Shen S.S. and Prieto V.G. (2005). Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms. J. Cutan. Pathol. 32, 533-536.
12. Dhawan P., Singh A.B., Deane N.G., No Y., Shiou S.R., Schmidt C., Neff J., Washington M.K. and Beauchamp R.D. (2005). Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J. Clin. Invest. 115, 1765-1776.
13. Flores-Benítez D., Ruiz-Cabrera A., Flores-Maldonado C., Shoshani L., Cereijido M. and Contreras R.G. (2007). Control of tight junctional sealing: role of epidermal growth factor. Am. J. Physiol. Renal. Physiol. 292, F828-F836.
14. Hahn H.P., Bundock E.A. and Hornick J.L. (2006). Immunohisto-chemical staining for claudin-1 can help distinguish meningiomas from histologic mimics. Am. J. Clin. Pathol. 125, 203-208.
15. Halász J., Holczbauer A., Páska C., Kovács M., Benyó G., Verebély T., Schaff Z. and Kiss A. (2006). Claudin-1 and claudin-2 differentiate fetal and embryonal components in human hepatoblastoma. Hum. Pathol. 37, 555-561.
16. Hewitt K.J., Agarwal R. and Morin P.J. (2006). The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6, 186.
17. Hornsby C.D., Cohen C., Amin M.B., Picken M.M., Lawson D., Yin-Goen Q. and Young A.N. (2007). Claudin-7 immunohistochemistry in renal tumors: A candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling. Arch. Pathol. Lab. Med. 131, 1541-1546.
18. Hough C.D., Sherman-Baust C.A., Pizer E.S., Montz F.J., Im D.D., Rosenshein N.B., Cho K.R., Riggins G.J. and Morin P.J. (2000). Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res. 60, 6281-6287.
19. Kleinberg L., Holth A., Trope C.G., Reich R. and Davidson B. (2008). Claudin up-regulation in ovarian carcinoma effusions is associated with poor survival. Hum. Pathol. 39, 747-757.
20. Krämer F., White K., Kubbies M., Swisshelm K. and Weber B.H. (2000). Genomic organization of claudin-1 and its assessment in hereditary and sporadic cancer. Hum. Genet. 107, 249-256.
21. Kohno Y., Okamoto T., Ishibe T., Nagayama S., Shima Y., Nishijo K., Shibata K.R., Fukiage K., Otsuka S., Uejima D., Araki N., Naka N., Nakashima Y., Aoyama T., Nakayama T., Nakamura T. and Toguchida J. (2006). Expression of claudin 7 is tightly associated with epithelial structures in synovial sarcomas and regulated by an Ets family transcription factor, ELF3. J. Biol. Chem. 281, 38941-38450.
22. Kominsky S.L., Argani P., Korz D., Evron E., Raman V., Garrett E., Rein A., Sauter G., Kallioniemi O.P. and Sukumar S. (2003). Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 22, 2021-2033.
23. Kominsky S.L., Vali M., Korz D., Gabig T.G., Weitzman S.A., Argani P. and Sukumar S. (2004). Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am. J. Pathol. 164, 1627-1633.
24. Kulka J., Szász A.M., Németh Z., Madaras L., Schaff Z., Molnár I.A. and Tokés A.M. (2009). Expression of tight junction protein claudin-4 in basal-like breast carcinomas. Pathol. Oncol. Res. 15, 59-64.
25. Lechpammer M., Resnick M.B., Sabo E., Yakirevich E., Greaves W.O., Sciandra K.T., Tavares R., Noble L.C., Delellis R.A. and Wang L.J. (2008). The diagnostic and prognostic utility of claudin expression in renal cell neoplasms. Mod. Pathol. 21, 1320-1329
26. Lee S.K., Moon J., Park S.W., Song S.Y., Chung J.B. and Kang J.K. (2005). Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma. Oncol. Rep.13, 193-199.
27. Li L., Yao J.L., di Sant'agnese P.A., Bourne P.A., Picken M.M., Young A.N., Shen S.S. and Huang J. (2008). Expression of claudin-7 in benign kidney and kidney tumors. Int. J. Clin. Exp. Pathol. 1, 57-64.
28. Lódi C., Szabó E., Holczbauer A., Batmunkh E., Szíjártó A., Kupcsulik P., Kovalszky I., Paku S., Illyés G., Kiss A. amd Schaff Z. (2006). Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Mod. Pathol. 19, 460-469.
29. Long H., Crean C.D., Lee W.H., Cummings O.W. and Gabig T.G. (2001). Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res. 61, 7878-7881.
30. Michl P., Barth C., Buchholz M., Lerch M.M., Rolke M., Holzmann K.H., Menke A., Fensterer H., Giehl K., Lohr M., Leder G., Iwamura T., Adler G. and Gress T.M. (2003). Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res. 63, 6265-6271.
31. Miwa N., Furuse M., Tsukita S., Niikawa N., Nakamura Y. and Furukawa Y. (2000). Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res. 12, 469-476.
32. Miyamoto K., Kusumi T., Sato F., Kawasaki H., Shibata S., Ohashi M., Hakamada K., Sasaki M. and Kijima H. (2008). Decreased expression of claudin-1 is correlated with recurrence status in esophageal squamous cell carcinoma. Biomed. Res. 29, 71-76.
33. Moldvay J., Jäckel M., Páska C., Soltész I., Schaff Z. and Kiss A. (2007). Distinct claudin expression profile in histologic subtypes of lung cancer. Lung cancer 57, 159-167.
34. Morin P.J. (2005). Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res. 65, 9603-9606.
35. Morohashi S., Kusumi T., Sato F., Odagiri H., Chiba H., Yoshihara S., Hakamada K., Sasaki M. and Kijima H. (2007). Decreased expression of claudin-1 correlates with recurrence status in breast cancer. Int. J. Mol. Med. 20, 139-143
36. Nacht M., Ferguson A.T., Zhang W., Petroziello J.M., Cook B.P., Gao Y.H., Maguire S., Riley D., Coppola G., Landes G.M., Madden S.L. and Sukumar S. (1999). Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res. 59, 5464-5470.
37. Nakanishi K., Ogata S., Hiroi S., Tominaga S., Aida S. and Kawai T. (2008). Expression of occludin and claudins 1, 3, 4, and 7 in urothelial carcinoma of the upper urinary tract. Am. J. Clin. Pathol. 130, 43-49.
38. Németh Z., Szász A.M., Tátrai P., Németh J., Gyorffy H., Somorácz A., Szíjártó A., Kupcsulik P., Kiss A. and Schaff Z. (2008). Claudin-1, -2, -3, -4, -7, -8 and -10 protein expression in biliary tract cancers. J Histochem. Cytochem. 57, 113-121.
39. Nichols L.S., Ashfaq R. and Iacobuzio-Donahue C.A. (2004). Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am. J. Clin. Pathol. 121, 226-230.
40. Oku N., Sasabe E., Ueta E., Yamamoto T. and Osaki T. (2006). Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res. 66, 5251-5257.
41. Oskunkoya A.O., Cohen C., Lawson D., Picken M.M., Amin M.B. amd Young A.N. (2008). Claudin-7 and claudin-8: Immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. Hum. Pathol. 40, 206-210.
42. Pan X.Y., Wang B., Che Y.C., Weng Z.P., Dai H.Y. and Peng W. (2007). Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue. Int. J. Gynecol. Cancer 17, 233-241.
43. Paschoud S., Bongiovanni M., Pache J.C. and Citi S. (2007). Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. Mod. Pathol. 29, 947-954.
44. Rangel L.B., Sherman-Baust C.A., Wernyj R.P., Schwartz D.R., Cho K.R. and Morin P.J. (2003). Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene 22, 7225-7232.
45. Saladik D.T., Soler A.P., Lewis S.A. and Mullin J.M. (1995). Cell division does not increase transepithelial permeability of LLC-PK1 cell sheets. Exp. Cell. Res. 220, 446-455.
46. Sheehan G.M., Kallakury B.V., Sheehan C.E., Fisher H.A., Kaufman R.P. Jr and Ross J.S. (2007). Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum. Pathol. 38, 564-569.
47. Schuetz A.N., Rubin B.P., Goldblum J.R., Shehata B., Weiss S.W., Liu W., Wick M.R. and Folpe A.L. (2005). Intercellular junctions in Ewing sarcoma/primitive neuroectodermal tumor: additional evidence of epithelial differentiation. Mod. Pathol.18, 1403-1410.
48. Sobel G., Németh J., Kiss A., Lotz G., Szabó I., Udvarhelyi N., Schaff Z. and Páska C. (2006). Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma. Gynecol. Oncol. 103, 591-598.
49. Soini Y. (2004). Claudins 2, 3, 4 and 5 in Paget's disease and breast carcinoma. Hum. Pathol. 35, 1531-1536
50. Soini Y. and Talvensaari-Mattila A. (2006). Expression of claudins 1, 4, 5 and 7 in ovarian tumors of diverse types. Int. J. Gynecol. Pathol. 25, 330-335.
51. Soini Y., Tommola S., Helin H. and Martikainen P. (2006a). Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype. Virchows Arch. 448, 52-58.
52. Soini Y., Kinnula V., Kahlos K. and Pääkkö P. (2006b). Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura. J. Clin. Pathol. 59, 250-254.
53. Soler A.P., Laughlin K.V. and Mullin J.M. (1993). Effects of epidermal growth factor versus phorbol ester on kidney epithelial (LLC-PK1) tight junction permeability and cell division. Exp. Cell. Res. 207, 398-406.
54. Swisshelm K., Macek R. and Kubbies M. (2005). Role of claudins in tumorigenesis. Adv. Drug Deliv. Rev. 25, 57,919-928.
55. Takala H., Saarnio J., Wiik H. and Soini Y. (2007). Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior. APMIS 115, 838-847.
56. Tokes A.M., Kulka J., Paku S., Szik A., Paska C., Novak P.K., Szilak L., Kiss A., Bogi K. and Schaff Z. (2005). Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res. 7, R296-305.
57. Tsukahara M., Nagai H., Kamiakito T., Kawata H., Takayashiki N., Saito K. and Tanaka A. (2005). Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas. Pathol. Int. 55, 63-69.
58. Tsukita S. and Furuse M. (2000). The structure and function of claudins, cell adhesion molecules at tight junctions. Ann. NY Acad. Sci. 915, 129-135
59. Tzelepi V.N., Tsamandas A.C., Vlotinou H.D., Vagianos C.E. and Scopa C.D. (2008). Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms. Mod. Pathol. 21, 22-30.
60. Van Itallie C.M. and Anderson J.M. (2006). Claudins and epithelial paracellular transport. Annu. Rev. Physiol. 68,403-429
61. Väre P., Loikkanen I., Hirvikoski P. and Vaarala M.H. and Soini Y. (2008). Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma. Oncol. Rep. 19, 25-31.
62. Zhu Y., Brännström M., Janson P.O. and Sundfeldt K. (2006). Differences in expression patterns of the tight junction proteins, claudin 1, 3, 4 and 5 in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumors. Int. J. Cancer 118, 1884-1891.